Financial Ratios

TWILIGHT LITAKA PHARMA LTD.

NSE : NABSE : 506985ISIN CODE : INE783B01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE2.880 (0 %)
PREV CLOSE ( ) 2.88
OPEN PRICE ( ) 2.88
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2.88 (112420)
VOLUME 2574
TODAY'S LOW / HIGH ( )2.88 2.88
52 WK LOW / HIGH ( ) 2.882.88
NSE
This Company is not listed in NSE
Select year
ParticularsJun2014Jun2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)-56.32-65.661.4223.2315.33
   CEPS(Rs)-54.32-63.083.4824.9516.77
   DPS(Rs)0.000.000.001.501.50
   Book NAV/Share(Rs)-51.035.2970.9664.6543.64
   Tax Rate(%)0.000.0020.7221.9919.55
Margin Ratios
   Core EBITDA Margin(%)-27.78-12.199.3614.8513.59
   EBIT Margin(%)-441.75-47.926.7514.7813.52
   Pre Tax Margin(%)-443.05-48.200.619.598.22
   PAT Margin (%)-443.05-48.200.487.486.61
   Cash Profit Margin (%)-427.27-46.311.188.037.23
Performance Ratios
   ROA(%)-36.88-32.760.6811.8010.12
   ROE(%)0.00-172.232.2542.9141.60
   ROCE(%)-55.60-40.5411.2427.9725.66
   Asset Turnover(x)0.080.681.421.581.53
   Sales/Fixed Asset(x)0.262.816.607.106.30
   Working Capital/Sales(x)-0.17-5.297.576.892.16
Efficiency Ratios
   Fixed Capital/Sales(x)3.820.360.150.140.16
   Receivable days2660.97315.39145.25120.37119.08
   Inventory Days342.6071.4940.2842.3944.72
   Payable days453.1537.1224.1822.3320.71
Valuation Parameters
   PER(x)0.000.0026.012.416.04
   PCE(x)-0.11-0.0610.622.255.53
   Price/Book(x)-0.120.740.520.872.12
   Yield(%)0.000.000.002.681.62
   EV/Net Sales(x)10.190.940.540.570.79
   EV/Core EBITDA(x)-36.70-7.735.633.695.54
   EV/EBIT(x)-2.31-1.967.923.835.79
   EV/CE(x)1.020.720.710.781.07
   M Cap / Sales0.480.030.130.180.40
Growth Ratio
   Net Sales Growth(%)-90.67-53.7811.0833.6232.80
   Core EBITDA Growth(%)78.63-158.83-31.3045.2334.98
   EBIT Growth(%)13.96-427.00-49.3546.4135.83
   PAT Growth(%)14.22-4722.34-92.8851.5547.48
   EPS Growth(%)14.22-4722.34-93.8951.5547.48
Financial Stability Ratios
   Total Debt/Equity(x)-2.4323.411.721.872.10
   Current Ratio(x)0.530.831.311.375.25
   Quick Ratio(x)0.520.691.061.043.97
   Interest Cover(x)-339.94-166.251.102.852.55
   Total Debt/Mcap(x)20.3331.613.302.160.99

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.